Similarly, tumor-associated CD40 expression has a favorable prognostic effect in renal cell carcinoma and diffuse large B-cell lymphoma following chemotherapy (Weiss et al., 2014;Rydstrom et al., 2010). The gene discussed is CD40; the disease is renal cell carcinoma.